COMPARATIVE STUDY BETWEEN PALETELET RICH PLASMA VS CONVENTIONAL DRESSING IN HEALING OF CHRONIC FOOT ULCER IN DIABETIC PATIENTS – A PROSPECTIVE RANDOMIZED CONTROL TRIAL

Ray Ganapathy, Anand Shanmugaiah

Abstract


Background : Chronic non healing ulcer has become a great challenge in diabetic patients. platelet rich plasma is used as it is enriched with growth
factors to enhance healing of these chronic wounds in diabetic patients and its efficacy is compared with conventional dressing.
Methods: This study was conducted in Indira Gandhi Medical College and hospital, pondicherry from august 2019 to October 2019. A total of 72
diabetic patients admitted for non healing foot ulcer was taken up for this study. 36 patients was treated with conventional dressing and 36 patients
was treated with platelet rich plasma dressing(PRP). Size of wound , duration and cost were compared between these two groups.
Results: Healing was better in patients who were given PRP dressing compared to conventional dressing based on reduction in size of the wound
by 6 weeks.
Conclusion : Autologous PRP is effective and safe in diabetic patients with chronic non healing foot ulcer


Keywords


PRP , conventional dressing , diabetic foot ulcer

Full Text:

PDF

References


Apelqvist G, Ragnarson U, Persson J, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation. J Int Med. 1994;235:463- 71.

Loot MA, Kenter SB, Au FL. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGF-I, bFGF and PDGF- AB compared to controls. Eur J Cell Biol. 2002;81:1530-60

Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg. 2006;117:143s-9s.

Ronfard V, Williams T. Developments in cell-based therapy for wounds. In: Ronfard V, Williams T, editors. Advances in wound care. Volume. New Rochelle, NY: Mary Ann Liebert Inc. Publications; 2012;1:412-8.

Blume P, Driver V, Tallis A. Formulated collagen gel accelerates healing rate immediately after application in patients with diabetic foot ulcers. Wound Repair Regen. 2011;19:302-8.

Russell R, Apostolakos J, Hirose T, Cote M, Mazzocca A. Variability of platelet-rich plasma preparations. Sports Med Arthrosc. 2013;21:186-90.

Marques L, Stessuk T, Camargo I, Junior SN, Santos L, Ribeiro-Paes J. Platelet-rich plasma (PRP): methodological aspects and clinical applications. Platelets. 2015;26:101-13.

Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008;1:165-74.

Giacco F, Perruolo G, D’Agostino E, Fratellanza G, Perna E, Misso S, et al. Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1. FASEB J. 2006;20:2402-4.

Moshiri A, Oryan A. Role of platelet rich plasma in soft and hard connective tissue healing: an evidence based review from basic to clinical application. Hard Tissue. 2013;2:6.

Kathleen M, Lacci B, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83:1-9.

Anitua E, Aguirre J, Algorta J, Ayerdi E, Cabezas A, Orive G, Andia I. Effectiveness of autologous preparation rich in growth factors for the treatment of cutaneous ulcers. J Biomed Mater Res Part B Appl Biomater. 2008;84:415-21.

De Leon MJ, Driver VR, Fylling CP, Carter MJ, Anderson C, Wilson J, et al. The clinical relevance of treating chronic wounds with an enhanced nearphysiological concentration of PRP gel. Adv Skin Wound Care. 2011;24:357-68.

Saad H, Elshahat A, Elsherbiny K, Massoud K, Safe I. Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wound J. 2011;8:307-12.

Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4:67.

Delbridge L, Ctercteko G, Fowler C, Reeve T, Le Quesne L. The etiology of diabetic neuropathic ulceration of the foot. Br J Surg. 2006;72:1-6.

Gui-Qiu S, Ya-Ni Zhang B, Jing M, Yan-Hui L, Da- Ming Z, Jin-Lang Q, et al. Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes. Int J Low Extrem Wounds. 2013;12:22-9.

Villela V, Falanga A, Brem H, Ennis W, Wolcott R, Gould L, et al. Role of PRP and maintenance debridement in treatment of difficult-to-heal Chronic wounds. Ostomy Wound Manage. 2010:2- 13.

Gelf JM, Hoffstad OZ, Margolis DJ. Surrogate endpoints for the treatment of diabetic leg ulcers. J Invest Dermatol. 2012;119:1420-5.


Refbacks

  • There are currently no refbacks.